This product(s) resides on a APICMO contract.
The ability to produce, synthesize and manufacture large quantities of 3,6-difluoropyrazine-2-carbonitrile (356783-28-3) with quality control system under CGMP manufacturing
3,6-difluoropyrazine-2-carbonitrile (356783-28-3) Description
3,6-difluoropyrazine-2-carbonitrile is a useful fluorinated building block and production intermediate in the synthesis of 3,6-difluoropyrazine-2-carbonitrile commercially named favipiravir, which is a unique viral RNA Polymerase inhibitor for the treatment of Influenza, acting on viral genetic copying to prevent its reproduction.
Synthesis and crystal structure of 6-fluoro-3-hydroxypyrazine-2-carboxamide. A practical and step-economic route to Favipiravir.
Favipiravir was approved for marketing in Japan in March 2014 and used for antiviral treatment of influenza A and B. In addition to the influenza virus, the drug also showed good antiviral activity to a variety of RNA viruses, such as Ebola virus, sand virus, Bunia virus, rabies virus, etc. Novel coronavirus pneumonia is inhibited by the latest research
This product(s) resides on a APICMO contract. If you are viewing this page as a non-registered user, the price(s) displayed is List Price. To view your pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. To place an order, contact APICMO Customer Service.
3,6-difluoropyrazine-2-carbonitrile (356783-28-3) Specifications
|Chemical Name or Material
AKOS005166866; AMPZ0001; DTXSID00627392 BCP28347; QC-769;
|Aluminum Foil Bag
|Molecular Weight (g/mol)
|White to Yellow Solid
|206.5±35.0°C at 760 mmHg
For research use only. Not for diagnostic or therapeutic use or human use.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Bulk Ordering & Pricing:
Need larger quantities for your development, manufacturing or research applications?